Trends in the diagnostic prevalence of cannabis-related disorders and co-occurring psychiatric disorders in adolescents: analysis of German health insurance data from 2013 to 2022
Open Access
- 9 January 2026
- journal article
- Published by Oxford University Press (OUP) in European Journal of Public Health
- Vol. 36 (2)
Abstract
Cannabis use can have detrimental effects on adolescents’ mental health, often co-occurring with child and adolescent psychiatric disorders (CAPD). This study assessed diagnostic prevalence trends in cannabis-related disorders and co-occurring diagnosed CAPD in adolescents receiving outpatient treatment in Germany. Outpatient claims data from the national public health insurance system, covering almost 4 million children and adolescents, were assessed for diagnostic prevalence of cannabis-related disorders (ICD-10 diagnoses F12.X) in insurees aged 12 to 17 years for the years 2013–22, stratified by age group and sex. In addition, the diagnostic prevalence of co-occurring CAPD during the year 2022 was evaluated. From 2013 to 2022, the diagnostic prevalence of cannabis-related disorders among German adolescents utilizing outpatient services increased from 0.08% to 0.10% (+22.4%), with a decline during the COVID-19 pandemic and a higher diagnostic prevalence in older adolescents. Up to 14 years of age, the diagnostic prevalence of cannabis-related disorders was distributed evenly among males and females, while from age 15 onwards, the diagnostic prevalence was higher in males. Overall, 78.3% of adolescents diagnosed with cannabis-related disorders had at least one co-occurring CAPD diagnosis in 2022. Most common co-occurring conditions were depressive disorders, conduct disorders, adjustment disorders, attention-deficit/hyperactivity disorders, and anxiety disorders. Co-occurring depression was particularly often diagnosed, underscoring the urgent need for integrated treatment approaches addressing both disorders simultaneously in this age group.Keywords
This publication has 30 references indexed in Scilit:
- Cannabis Use Is Associated With Depression Severity and Suicidality in the National Comorbidity Survey−Adolescent SupplementJAACAP Open, 2023
- Prevalence of substance use disorders and associations with mindfulness, impulsive personality traits and psychopathological symptoms in a representative sample of adolescents in GermanyEuropean Child & Adolescent Psychiatry, 2023
- Cannabis legalization and cannabis use, daily cannabis use and cannabis-related problems among adults in Ontario, Canada (2001–2019)Drug and Alcohol Dependence, 2023
- Prevalence and modes of cannabis use among youth in Canada, England, and the US, 2017 to 2019Drug and Alcohol Dependence, 2021
- Association of Cannabis Use in Adolescence and Risk of Depression, Anxiety, and Suicidality in Young AdulthoodJAMA Psychiatry, 2019
- Cannabis use and cannabis use disorders among individuals with mental illnessComprehensive Psychiatry, 2013
- Probability and predictors of transition from first use to dependence on nicotine, alcohol, cannabis, and cocaine: Results of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC)Drug and Alcohol Dependence, 2011
- Lifetime Prevalence of Mental Disorders in U.S. Adolescents: Results from the National Comorbidity Survey Replication–Adolescent Supplement (NCS-A)Journal of the American Academy of Child & Adolescent Psychiatry, 2010
- Early-onset drug use and risk for drug dependence problemsAddictive Behaviors, 2009
- Specificity of social anxiety disorder as a risk factor for alcohol and cannabis dependenceJournal of Psychiatric Research, 2008